Literature DB >> 26096723

Inappropriate prescribing of intravenous fluid in adult inpatients-a literature review of current practice and research.

X Gao1, K-P Huang1, H-Y Wu1, P-P Sun1, J-J Yan1, J Chen1, X Chen1.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: It is known that mismanagement of intravenous (IV) fluid therapy may cause serious complications. The 2013 NICE guideline on intravenous fluid therapy in hospitalized adults also emphasizes the importance of appropriate prescribing of IV fluid. So far, no systematic review of the incidence and types of inappropriate prescribing of IV fluid has been conducted. Therefore, this study was undertaken to review the research literature on inappropriate prescribing of IV fluid in adult patients and develop corresponding strategies for improving practice.
METHODS: A comprehensive literature search was performed. Critical appraisals were conducted on the articles drawn from the search, and an analysis was performed on the results. RESULTS AND DISCUSSION: Incorrect volumes and types of IV fluids prescribed, classified as misprescribing, was the most common type of inappropriate prescribing. Commonly, patients on IV fluid therapy were prescribed a greater volume of fluid and amount of sodium in excess of normal requirements. Doctors did not always check the body weight, serum electrolyte level and serum creatinine before prescribing IV fluid for patients. The other common type of inappropriate prescribing was incomplete/incorrect prescription writing. These common inappropriate prescribing of IV fluid could be caused by insufficient knowledge and training of the prescribers. In addition, the ignorance of the importance of IV fluid prescribing also contributed to this behaviour. WHAT IS NEW AND
CONCLUSION: There is an urgent need to make doctors aware of these problems and enhance appropriate training on IV fluid prescribing, especially on the appropriate volume and amount of electrolytes. Pharmacists could exert a role in reviewing the fluid prescription chart for improving clinical practice.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  inappropriate prescribing; intravenous fluid therapy; review

Year:  2015        PMID: 26096723     DOI: 10.1111/jcpt.12295

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  7 in total

1.  Fluid and electrolyte management: increasing the knowledge of House Officers using an interactive eLearning tool.

Authors:  Freya Bakko; Annabel Brown; Micol Lupi; Robert M Maweni
Journal:  Ir J Med Sci       Date:  2022-07-13       Impact factor: 2.089

2.  Development and validation of an audit tool for fluid management in non-critically ill adults in the emergency department.

Authors:  Sabien Vleeschouwers; Stephanie C M Wuyts; Simon Scheyltjens; Maarten Vandendriessche; Pieter Cornu; Ives Hubloue
Journal:  Intern Emerg Med       Date:  2022-09-25       Impact factor: 5.472

3.  Drowning in antibiotics.

Authors:  C L Gelder; S Robinson; F Leitch; A J McMahon
Journal:  Ann R Coll Surg Engl       Date:  2022-05-31       Impact factor: 1.951

4.  Pharmacist intervention to enhance postoperative fluid prescribing practice in an Iraqi hospital through implementation of NICE guideline.

Authors:  Sarah K Abbood; Hayder C Assad; Ali A Al-Jumaili
Journal:  Pharm Pract (Granada)       Date:  2019-08-29

5.  Advantages in Management and Remote Monitoring of Intravenous Therapy: Exploratory Survey and Economic Evaluation of Gravity-Based Infusions in Finland.

Authors:  Antti Puolitaival; Mikko Savola; Petri Tuomainen; Christian Asseburg; Tuomas Lundström; Erkki Soini
Journal:  Adv Ther       Date:  2022-03-14       Impact factor: 4.070

Review 6.  Learning to prescribe intravenous fluids: A scoping review.

Authors:  Richard F R McCrory; Gerard Joseph Gormley; Alexander Peter Maxwell; Tim Dornan
Journal:  Perspect Med Educ       Date:  2017-12

7.  Intravenous fluid prescribing errors in children: Mixed methods analysis of critical incidents.

Authors:  Richard L Conn; Steven McVea; Angela Carrington; Tim Dornan
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.